ArticleJournal of clinical medicine2024

Baseline Predictors of Adverse Outcomes for Transthyretin Amyloidosis Cardiomyopathy Patients Treated and Untreated with Tafamidis: A Canadian Referral Center Experience.

Karan Shahi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.